Could a one-week radiation zap be just as good as three weeks for early breast cancer?
NCT ID NCT05318274
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a 1-week radiation schedule to the standard 3.1-week schedule for people with early-stage breast cancer who have had lumpectomy. The goal is to see if the shorter course controls cancer just as well while causing fewer side effects. About 72 adults with ductal carcinoma in situ or early invasive breast cancer are taking part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCTAL BREAST CARCINOMA IN SITU are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Unidad Medica de Alta Especialidad
Mérida, Yucatán, 97150, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Less radiation for breast cancer? a trial tests a smarter, response-based approach
- Skipping the armpit: a trial tests whether partial breast radiation alone is enough
- Proton beam aims to spare healthy tissue after breast cancer surgery
- Can walking flush out hidden toxins? new study tests exercise against PFAS
- Major trial tests whether skipping armpit surgery after sentinel node cancer is safe for breast cancer patients
- Can shedding pounds after breast cancer keep it away?